| SD |
heart rate |
sham surgical control condition (for 6 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
heart pumping trait |
male |
days
| 6 |
385.0 |
beats/min |
11.0 |
26.94 |
HP Sonos 5500 echo ultrasound |
|
1.0 |
sham ACF |
360 |
min |
98794 |
2160 |
| SD |
heart rate |
sham surgical control condition (for 12 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
heart pumping trait |
male |
days
| 6 |
395.0 |
beats/min |
11.0 |
26.94 |
HP Sonos 5500 echo ultrasound |
|
1.0 |
sham ACF |
720 |
min |
98796 |
2160 |
| SD |
heart rate |
sham surgical control condition (for 2 days) then vehicle control condition (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
heart pumping trait |
male |
days
| 6 |
380.0 |
beats/min |
10.0 |
24.49 |
HP Sonos 5500 echo ultrasound |
|
1.0 |
sham ACF |
2 |
days |
98802 |
2160 |
| SD |
heart rate |
sham surgical control condition (for 2 days) then metoprolol succinate (100 mg/kg/d) (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
heart pumping trait |
male |
days
| 6 |
365.0 |
beats/min |
7.0 |
17.15 |
HP Sonos 5500 echo ultrasound |
|
1.0 |
sham ACF |
2 |
days |
98805 |
2160 |
| WF/Mol |
heart rate |
vehicle control condition then sham surgical control condition (for 2 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
heart pumping trait |
male |
days
| 6 |
377.0 |
beats/min |
11.0 |
26.94 |
tail cuff plethysmography |
|
0.0 |
sham acf |
2 |
days |
101379 |
2585 |
| WF/Mol |
heart rate |
vehicle control condition then sham surgical control condition (for 4 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
heart pumping trait |
male |
days
| 5 |
406.0 |
beats/min |
22.0 |
49.19 |
tail cuff plethysmography |
|
0.0 |
sham acf |
4 |
days |
101369 |
2585 |
| WF/Mol |
heart rate |
vehicle control condition then sham surgical control condition (for 7 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
heart pumping trait |
male |
days
| 5 |
382.0 |
beats/min |
8.0 |
17.89 |
tail cuff plethysmography |
|
0.0 |
sham acf |
7 |
days |
101388 |
2585 |
| SD |
heart rate |
sham surgical control condition (for 105 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart pumping trait |
male |
175.0 days
| 10 |
217.0 |
beats/min |
12.0 |
37.95 |
vascular transducer tipped catheter |
|
0.0 |
sham ACF |
105 |
days |
99217 |
2278 |
| SD |
heart rate |
sham surgical control condition (for 2 days) then Aprotinin (12000 kIU) (for 2 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart pumping trait |
male |
72.0 days
| 5 |
371.0 |
beats/min |
4.0 |
8.94 |
vascular transducer tipped catheter |
|
0.0 |
sham ACF |
2 |
days |
99293 |
2278 |
| WF/Mol |
heart rate |
controlled losartan content drinking water (10 mg/kg/d) (for 8 days) then sham surgical control condition (for 7 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
heart pumping trait |
male |
days
| 6 |
407.0 |
beats/min |
16.0 |
39.19 |
tail cuff plethysmography |
|
0.0 |
sham acf |
7 |
days |
101385 |
2585 |
| HsdCpb:WU |
heart rate |
sham surgical control condition |
Szymanski MK, etal., Basic Res Cardiol. 2012 Mar;107(2):242. doi: 10.1007/s00395-011-0242-4. Epub 2012 Jan 19. |
heart pumping trait |
male |
175.0 days
| 10 |
331.0 |
beats/min |
14.0 |
44.27 |
vascular indwelling catheter method |
heart |
0.0 |
|
|
|
108838 |
3130 |
| SD |
heart rate |
sham surgical control condition (between 120 and 12 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
heart pumping trait |
male |
days
| 6 |
365.0 |
beats/min |
15.0 |
36.74 |
HP Sonos 5500 echo ultrasound |
|
1.0 |
sham ACF |
5 |
days |
98800 |
2160 |
| SD |
heart rate |
sham surgical control condition (for 28 days) then Aprotinin (12000 kIU) (for 28 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart pumping trait |
male |
98.0 days
| 7 |
312.0 |
beats/min |
5.0 |
13.23 |
vascular transducer tipped catheter |
|
0.0 |
sham ACF |
28 |
days |
99297 |
2278 |
| HsdCpb:WU |
heart rate |
sham surgical control condition |
Szymanski MK, etal., Basic Res Cardiol. 2012 Mar;107(2):242. doi: 10.1007/s00395-011-0242-4. Epub 2012 Jan 19. |
heart pumping trait |
male |
84.0 days
| 5 |
359.0 |
beats/min |
18.0 |
40.25 |
vascular indwelling catheter method |
heart |
0.0 |
|
|
|
108778 |
3130 |
| WF/Mol |
heart rate |
controlled losartan content drinking water (10 mg/kg/d) (for 5 days) then sham surgical control condition (for 4 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
heart pumping trait |
male |
days
| 6 |
410.0 |
beats/min |
8.0 |
19.6 |
tail cuff plethysmography |
|
0.0 |
sham acf |
4 |
days |
101381 |
2585 |
| WF/Mol |
heart rate |
controlled ramipril content drinking water (3 mg/kg/d) (for 8 days) then sham surgical control condition (for 7 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
heart pumping trait |
male |
days
| 5 |
402.0 |
beats/min |
31.0 |
69.32 |
tail cuff plethysmography |
|
0.0 |
sham acf |
7 |
days |
101371 |
2585 |
| WF/Mol |
heart rate |
vehicle control condition then sham surgical control condition (for 7 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
heart pumping trait |
male |
days
| 5 |
358.0 |
beats/min |
12.0 |
26.83 |
tail cuff plethysmography |
|
0.0 |
sham acf |
7 |
days |
101373 |
2585 |
| SD |
heart rate |
sham surgical control condition (for 2 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart pumping trait |
male |
72.0 days
| 5 |
359.0 |
beats/min |
6.0 |
13.42 |
vascular transducer tipped catheter |
|
0.0 |
sham ACF |
2 |
days |
99291 |
2278 |
| SD |
heart rate |
sham surgical control condition (for 28 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart pumping trait |
male |
98.0 days
| 7 |
321.0 |
beats/min |
7.0 |
18.52 |
vascular transducer tipped catheter |
|
0.0 |
sham ACF |
28 |
days |
99295 |
2278 |
| MWF/Hsd |
heart rate |
sham surgical control condition |
Szymanski MK, etal., Basic Res Cardiol. 2012 Mar;107(2):242. doi: 10.1007/s00395-011-0242-4. Epub 2012 Jan 19. |
heart pumping trait |
male |
84.0 days
| 5 |
364.0 |
beats/min |
14.0 |
31.3 |
vascular indwelling catheter method |
heart |
0.0 |
|
|
|
108779 |
3130 |
| MWF/Hsd |
heart rate |
sham surgical control condition |
Szymanski MK, etal., Basic Res Cardiol. 2012 Mar;107(2):242. doi: 10.1007/s00395-011-0242-4. Epub 2012 Jan 19. |
heart pumping trait |
male |
175.0 days
| 9 |
364.0 |
beats/min |
28.0 |
84.0 |
vascular indwelling catheter method |
heart |
0.0 |
|
|
|
108840 |
3130 |
| SD |
heart rate |
sham surgical control condition (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
heart pumping trait |
male |
days
| 6 |
389.0 |
beats/min |
9.0 |
22.05 |
HP Sonos 5500 echo ultrasound |
|
1.0 |
sham ACF |
2 |
days |
98798 |
2160 |
| SD |
heart rate |
sham surgical control condition (for 28 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart pumping trait |
male |
98.0 days
| 8 |
260.0 |
beats/min |
12.0 |
33.94 |
vascular transducer tipped catheter |
|
0.0 |
sham ACF |
28 |
days |
99215 |
2278 |
| WF/Mol |
heart rate |
controlled losartan content drinking water (10 mg/kg/d) (for 3 days) then sham surgical control condition (for 2 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
heart pumping trait |
male |
days
| 5 |
424.0 |
beats/min |
10.0 |
22.36 |
tail cuff plethysmography |
|
0.0 |
sham acf |
2 |
days |
101377 |
2585 |
| WF/Mol |
heart rate |
controlled ramipril content drinking water (3 mg/kg/d) (for 5 days) then sham surgical control condition (for 4 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
heart pumping trait |
male |
days
| 5 |
366.0 |
beats/min |
14.0 |
31.3 |
tail cuff plethysmography |
|
0.0 |
sham acf |
4 |
days |
101367 |
2585 |
| WF/Mol |
heart rate |
vehicle control condition then sham surgical control condition (for 4 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
heart pumping trait |
male |
days
| 5 |
366.0 |
beats/min |
12.0 |
26.83 |
tail cuff plethysmography |
|
0.0 |
sham acf |
4 |
days |
101383 |
2585 |
| WKY |
heart rate |
sham surgical control condition (for 224 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart pumping trait |
male |
266.0 days-280.0 days |
5 |
398.0 |
beats/min |
37.0 |
82.73 |
echocardiography |
|
0.0 |
lad occlusion sham |
210 |
days |
100312 |
2460 |